{"mainPropery":{"diseaseId":9508,"diseaseName":"Cerulean cataract","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/9508/cerulean-cataract","synonyms":["Cataract, congenital, cerulean type 1","CCA1","Cataract, congenital, blue dot type 1"],"synonyms-with-source":[{"name":"Cataract, congenital, cerulean type 1"},{"name":"CCA1"},{"name":"Cataract, congenital, blue dot type 1"}],"identifiers":[{"identifierType":"OMIM","identifierId":"115660"},{"identifierType":"OMIM","identifierId":"601547"},{"identifierType":"OMIM","identifierId":"608983"},{"identifierType":"OMIM","identifierId":"610202"},{"identifierType":"ORPHANET","identifierId":"98989"},{"identifierType":"UMLS","identifierId":"C0344523"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":9,"diseaseTypeName":"Eye diseases","source":"Orphanet"}],"organizations":[{"resourceID":110,"resourceName":"National Alliance for Eye and Vision Research ","abbreviation":"NAEVR","address1":"1801 Rockville Pike, Suite 400","address2":"","address3":"","address4":"","address5":"","city":"Rockville","state":"MD","zip":"20852","country":"United States","phone":"+1-240-221-2905","tty":"","tollFree":"","fax":"","email":"jamesj@eyeresearch.org","url":"https://www.eyeresearch.org/","freeText":""},{"resourceID":478,"resourceName":"Vision of Children Foundation ","abbreviation":"VOC","address1":"12555 High Bluff Drive, Suite 330","address2":"","address3":"","address4":"","address5":"","city":"San Diego","state":"CA","zip":"92130 ","country":"United States","phone":"+1-858-314-7916","tty":"","tollFree":"","fax":"","email":"info@visionofchildren.org","url":"https://www.visionofchildren.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"Online Mendelian Inheritance in Man (OMIM) is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n<a href='http://www.omim.org/115660' target='_blank'>CATARACT, CONGENITAL, CERULEAN TYPE, 1; CCA1</a><br /><a href='http://www.omim.org/601547' target='_blank'>CATARACT, CONGENITAL, CERULEAN TYPE, 2; CCA2</a><br /><a href='http://www.omim.org/608983' target='_blank'>CATARACT, CONGENITAL, CERULEAN TYPE, 3; CCA3</a><br /><a href='http://www.omim.org/610202' target='_blank'>CATARACT, PULVERULENT, JUVENILE-ONSET</a><br />","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=115660' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Cerulean cataract. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":111,"resourceId":972,"resourceName":"Centers for Mendelian Genomics","descriptionText":"The <a href='http://mendelian.org/' target='_blank'>Centers for Mendelian Genomics</a> program is working to discover the causes of rare genetic disorders. For more information about applying to the research study, please visit their website.","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/001615.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1210837-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=98989' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:115660' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":4306,"questionText":"What are cerulean cataracts?","answerText":"<strong>Cerulean cataracts </strong>are opaque areas that develop in the lens of the eye that often&nbsp;have a bluish or whitish&nbsp;color. They may be present at birth or develop in very early childhood, but may not be diagnosed until adulthood.[3238]&nbsp;They are usually bilateral and progressive.[3239] Infants can be asymptomatic, but may also be visually impaired from birth and develop <a href=\"http://www.aoa.org/x9763.xml\" target=_blank>nystagmus</a> and <a href=\"http://www.nei.nih.gov/health/amblyopia/amblyopia_guide.asp\" target=_blank>amblyopia</a>.[3239]&nbsp;In adulthood, the cataracts may progress, making lens removal necessary.[3238] Cerulean cataracts may be caused by&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=_blank>mutations</a> in several genes, including the <a href=\"http://ghr.nlm.nih.gov/gene/CRYBB2\" target=_blank>CRYBB2</a>, <a href=\"http://ghr.nlm.nih.gov/gene/CRYGD\" target=_blank>CRYGD</a>, and <a href=\"http://ghr.nlm.nih.gov/gene/MAF\" target=_blank>MAF</a>&nbsp;genes, and are inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=_blank>autosomal dominant</a> manner. No treatment is known to prevent&nbsp;cerulean cataracts,&nbsp;but frequent evaluations and cataract surgery are typically required to prevent amblyopia as the opacities progress.[3239]","dateModified":"2011-04-06T11:52:00"},"basicQuestions":[{"questionId":4308,"questionText":"How might cerulean cataracts be treated?","answerText":"No treatment is known to prevent cerulean cataracts, and there is currently no cure for the condition.&nbsp;Frequent eye&nbsp;evaluations and eventual&nbsp;cataract surgery are typically required to prevent <a href=\"http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002009/\" target=_blank>amblyopia</a> (vision loss) as the opacities progress.[3239] The symptoms of early cataracts may be improved with new eyeglasses, brighter lighting, anti-glare sunglasses, or magnifying lenses. However, if these measures do not help, surgery is often&nbsp;the only effective treatment. Surgery involves removing the cloudy lens and replacing it with an artificial lens. Surgery is often considered when vision loss regularly interferes with everyday activities, such as driving, reading, or watching TV.[3241]","dateModified":"2011-04-06T11:49:00","resourceClassificationName":"Treatment","references":[{"referenceId":3239,"authors":"","articleTitle":"Cataracts, Congenital Cerulean","bookWebsiteJournalTitle":"University of Arizone","date":"2010","url":"http://disorders.eyes.arizona.edu/disorders/cataracts-congenital-cerulean","dateAccessed":"2011-04-06T00:00:00"},{"referenceId":3241,"authors":"","articleTitle":"Facts About Cataract","bookWebsiteJournalTitle":"National Eye Institute","date":"April 2011","url":"http://www.nei.nih.gov/health/cataract/cataract_facts.asp","dateAccessed":"2011-04-06T00:00:00"}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":30241,"abbreviatedInquiry":"I&nbsp;recently had my eyes checked because I developed headaches, and I was diagnosed&nbsp;with blue dot cataracts. Is this a harmful condition? Is there a cure?","caseQuestions":[{"questionId":4306,"questionText":"What are cerulean cataracts?","answerText":"<strong>Cerulean cataracts </strong>are opaque areas that develop in the lens of the eye that often&nbsp;have a bluish or whitish&nbsp;color. They may be present at birth or develop in very early childhood, but may not be diagnosed until adulthood.[3238]&nbsp;They are usually bilateral and progressive.[3239] Infants can be asymptomatic, but may also be visually impaired from birth and develop <a href=\"http://www.aoa.org/x9763.xml\" target=_blank>nystagmus</a> and <a href=\"http://www.nei.nih.gov/health/amblyopia/amblyopia_guide.asp\" target=_blank>amblyopia</a>.[3239]&nbsp;In adulthood, the cataracts may progress, making lens removal necessary.[3238] Cerulean cataracts may be caused by&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=_blank>mutations</a> in several genes, including the <a href=\"http://ghr.nlm.nih.gov/gene/CRYBB2\" target=_blank>CRYBB2</a>, <a href=\"http://ghr.nlm.nih.gov/gene/CRYGD\" target=_blank>CRYGD</a>, and <a href=\"http://ghr.nlm.nih.gov/gene/MAF\" target=_blank>MAF</a>&nbsp;genes, and are inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=_blank>autosomal dominant</a> manner. No treatment is known to prevent&nbsp;cerulean cataracts,&nbsp;but frequent evaluations and cataract surgery are typically required to prevent amblyopia as the opacities progress.[3239]","dateModified":"2011-04-06T11:52:00","references":[{"referenceId":3238,"authors":"Marla J. F. O'Neill et al","articleTitle":"CATARACT, CONGENITAL, CERULEAN TYPE, 1; CCA1","bookWebsiteJournalTitle":"OMIM","date":"June 21, 2006","url":"http://www.ncbi.nlm.nih.gov/omim/115660","dateAccessed":"2011-04-06T00:00:00"},{"referenceId":3239,"authors":"","articleTitle":"Cataracts, Congenital Cerulean","bookWebsiteJournalTitle":"University of Arizone","date":"2010","url":"http://disorders.eyes.arizona.edu/disorders/cataracts-congenital-cerulean","dateAccessed":"2011-04-06T00:00:00"}]},{"questionId":4307,"questionText":"Are cerulean cataracts harmful?","answerText":"Cerulean cataracts are generally only harmful&nbsp;to an affected individual's vision; however,&nbsp;the vision loss associated with cerulean cataracts may reduce the individual's learning abilities or quality of life, or&nbsp;harm the individual's emotional and social well-being. No systemic abnormalities (those affecting other parts of the body, or the body as a whole) are associated with cerulean cataracts.[3239]","dateModified":"2011-04-06T11:53:00","references":[{"referenceId":3239,"authors":"","articleTitle":"Cataracts, Congenital Cerulean","bookWebsiteJournalTitle":"University of Arizone","date":"2010","url":"http://disorders.eyes.arizona.edu/disorders/cataracts-congenital-cerulean","dateAccessed":"2011-04-06T00:00:00"}]},{"questionId":4308,"questionText":"How might cerulean cataracts be treated?","answerText":"No treatment is known to prevent cerulean cataracts, and there is currently no cure for the condition.&nbsp;Frequent eye&nbsp;evaluations and eventual&nbsp;cataract surgery are typically required to prevent <a href=\"http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002009/\" target=_blank>amblyopia</a> (vision loss) as the opacities progress.[3239] The symptoms of early cataracts may be improved with new eyeglasses, brighter lighting, anti-glare sunglasses, or magnifying lenses. However, if these measures do not help, surgery is often&nbsp;the only effective treatment. Surgery involves removing the cloudy lens and replacing it with an artificial lens. Surgery is often considered when vision loss regularly interferes with everyday activities, such as driving, reading, or watching TV.[3241]","dateModified":"2011-04-06T11:49:00","resourceClassificationName":"Treatment","references":[{"referenceId":3239,"authors":"","articleTitle":"Cataracts, Congenital Cerulean","bookWebsiteJournalTitle":"University of Arizone","date":"2010","url":"http://disorders.eyes.arizona.edu/disorders/cataracts-congenital-cerulean","dateAccessed":"2011-04-06T00:00:00"},{"referenceId":3241,"authors":"","articleTitle":"Facts About Cataract","bookWebsiteJournalTitle":"National Eye Institute","date":"April 2011","url":"http://www.nei.nih.gov/health/cataract/cataract_facts.asp","dateAccessed":"2011-04-06T00:00:00"}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":14414,"phenoTypeName":"Cerulean cataract","frequencyText":"Obligate","percentRanges":"100%"},{"phenoTypeId":9326,"phenoTypeName":"Macular hypoplasia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5648,"phenoTypeName":"Retinal detachment","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":8346,"phenoTypeName":"Cortical pulverulent cataract","percentRanges":"-"},{"phenoTypeId":5625,"phenoTypeName":"Developmental cataract","percentRanges":"-"},{"phenoTypeId":9197,"phenoTypeName":"Iris coloboma","percentRanges":"-"},{"phenoTypeId":10488,"phenoTypeName":"Microcornea","percentRanges":"-"},{"phenoTypeId":15023,"phenoTypeName":"Mildly reduced visual acuity","percentRanges":"-"},{"phenoTypeId":4817,"phenoTypeName":"Nuclear pulverulent cataract","percentRanges":"-"},{"phenoTypeId":4809,"phenoTypeName":"Sutural cataract","percentRanges":"-"},{"phenoTypeId":9162,"phenoTypeName":"Visual loss","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Cerulean_cataract"}